Brief: Kuros Biosciences H1 Product Revenue CHF 31.844 Million
08/08/2024 06:02
Aug 08 (Reuters) - Kuros Biosciences H1 operating income CHF -559 thousand. * H1 EPS CHF -0.01 * H1 gross profit CHF 28.367 million * H1 net income CHF -211 thousand
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million